Ally Bridge Group (Ny) LLC Bolt Biotherapeutics, Inc. Transaction History

Ally Bridge Group (Ny) LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.19 - $13.97 $1.08 Million - $3.59 Million	-257,267 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$11.15 - $18.6 $1.73 Million - $2.88 Million	-155,000 Reduced 37.6%	257,267 $3.25 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $1.92 Million - $3.92 Million	124,542 Added 43.29%	412,267 $6.37 Million
Q1 2021 May 17, 2021	BUY	$25.86 - $39.93 $7.44 Million - $11.5 Million	287,725 New	287,725 $9.47 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $21.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.